Głuszczyk A, Plizga J, Makłowicz A, Kopczyńska E, Szpulak A, Frańczuk A, et al. Challenges and risks of using GLP-1 antagonists in treating type 2 diabetes and obesity. Qual Sport [Internet]. 2024 Aug. 16 [cited 2025 Dec. 25];17:53683. Available from: https://apcz.umk.pl/QS/article/view/53683